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Abstract 
 
A flow injection square wave cathodic stripping voltammetric method has been developed for the determination of sertraline in a pharmaceu- 
tical preparation. The method shows linearity between peak current intensity and sertraline concentration for the interval between 0.20 × 10−6 
and 1.20 × 10−6 mol L−1. Limits of detection and quantification were found to be 1.5 × 10−7 and 5.0 × 10−7 mol L−1, respectively. Up to 70 
samples per hour can be analysed with a good precision (R.S.D. = 2.5%). The proposed method was successfully applied to the determination 
of sertraline in a commercial product. In the voltammetric determination of sertraline in flow, a high sample rate is obtained at reduced costs, 
opening the possibility to compete with the chromatographic methods generally used for this analysis. 
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1. Introduction 
 
Sertraline (STR, Fig. 1), a member of the class of the 
selective serotonin reuptake inhibitors (SSRI), is a com- 
pound primarily used as an antidepressant drug but it is also 
applied in the correction of other psychic deviations like 
obsessive–compulsive, panic and posttraumatic stress disor- 
ders. 
For drug development and treatment purposes, it is of high 
importance to determine the concentration of the drug, and 
in some cases of its metabolites, in a wide variety of sam- 
ples (serum, plasma, urine and pharmaceuticals) in order to 
establish its pharmacokinetics, metabolic pathway, dosage, 
etc. This implies the need for the development of analytical 
methodologies, which provide high sample rates, low limits 
of detection and low maintenance costs. 
The determination of STR in serum and plasma is gen- 
erally performed by high performance liquid chromatogra- 
phy (HPLC) coupled with spectrophotometric detectors, ul- 
traviolet/diode array [1–6] and fluorimetric [7,8]. The wide 
 
 
spread usage of HPLC methods is justified by the high 
sensitivity and low limit of detection usually obtained and 
the possibility of the simultaneous analysis  of  the  drug 
and its metabolites, which increases its usage even further. 
The main disadvantages of HPLC are the relatively long 
analysis times and the high acquisition and maintenance 
costs. Several other methods based on micellar electroki- 
netic capillary chromatography [9], isotachophoresis [10], 
gas chromatography–mass spectrometry/nitrogen phospho- 
rus detector [11–15] and UV–vis spectrophotometry [16] 
have also been described. No assay methods for STR determi- 
nation are reported in the British, United States and European 
Union Pharmacopoeias. 
Until now, only one publication on the electrochemical 
study and analysis of STR has been published [17]. This 
study focused on the determination of the compound in a 
pharmaceutical product using square wave adsorptive strip- 
ping voltammetry under batch conditions. 
Besides its wide spread use in metal analysis, adsorptive 
stripping voltammetry is also adequate for the analysis of 
organic compounds, which can be accumulated at the hang- 
ing mercury drop electrode (HMDE) surface and afterwards 
stripped off by applying a potential scan [18]. The introduc- 
 
  
 
Fig. 1.  Chemical structure of sertraline. 
 
 
tion of high scan rate voltammetric techniques like square 
wave voltammetry allows increasing the sensitivity of AdSV 
even further [19,20]. 
In the present paper, the possibility of combining a flow 
injection system with a voltammetric detector, applying ad- 
sorptive stripping square wave voltammetry, for the determi- 
nation of STR in a pharmaceutical preparation was explored. 
Using the HMDE flow cell developed by Rodrigues et al. [21], 
it was possible to determine STR in flow at a high sample rate 
and reduced costs, opening the possibility to compete with the 
chromatographic methods generally used for this analysis. 
 
 
2. Experimental 
 
2.1. Apparatus 
 
Voltammetric measurements were performed using an Au- 
tolab PGSTAT12 (Metrohm-Eco Chemie), controlled by a PC 
with the GPES 4.9 software (Metrohm-Eco Chemie), linked 
to a Metrohm 663VA stand containing a three-electrode cell 
(all Metrohm). This cell consisted of a multimode mercury 
working electrode, used in the static mercury drop position, 
an Ag/AgCl/KCl 3 mol L−1 reference electrode, and a glassy 
carbon auxiliary electrode. 
The above described equipment was used as a  detector 
in a single manifold flow injection analysis (FIA) system. 
Samples and standards were introduced (Vinj = 500 µL) into 
the carrier stream through a six-port Rheodyne 5041 injection 
valve. The solutions were transported through the FIA system 
by a Gilson Minipuls 3 peristaltic pump, using PTFE carrier 
tubing (i.d. 0.8 mm), to the voltammetric HMDE cell. 
In the voltammetric flow cell used in this work [21], the 
glass capillary of the mercury electrode is inserted into a 
PTFE adapter head and the flow is directed towards the mer- 
cury drop. This adapter head allows a reproducible reposi- 
tioning of the glass capillary to be made whenever the flow 
cell is dismounted and then remounted. The adapter head to- 
gether with the reference electrode and the counter electrode 
are contained in a glass cell, which is filled with the solution 
 
used as the carrier stream. A drain ensures a constant level of 
solution to be maintained during the work. 
 
2.2. Reagents 
 
A sertraline hydrochloride standard was kindly offered by 
Pfizer Inc. All other chemicals were of analytical grade qual- 
ity. Deionised water (conductivity <0.1 µS cm−1) was used 
throughout. The supporting electrolyte was a borate buffer 
(pH 8.2; 0.1 M). 
Sertraline stock solutions (10−4 mol L−1) were prepared 
in methanol and stored at 4 ◦C. These  stock  solutions 
were further diluted with electrolyte solution or with an 
electrolyte–methanol mixture. 
 
2.3. Pharmaceutical preparation 
 
Five tablets of Zolof (50 mg STR/tablet) were weighed 
and finely powdered. About 20 mg of this powder was dis- 
solved in 25 mL of methanol with the help of an ultrasonic 
bath. The resulting solution was then filtered to eliminate 
non-dissolved excipient and diluted about 200 times, with 
an electrolyte–methanol mixture, to obtain the required STR 
concentration. Quantification of STR was carried out by the 
standard addition method. 
 
 
3. Results and discussion 
 
In the development of the flow injection voltammetric sys- 
tem for the determination of STR, it was important to consider 
the results previously reported by Vela et al. [17]: STR ad- 
sorbs at the HMDE and presents a reduction peak at   about 
−1.8 V versus AgCl/Ag in an electrolyte of pH 8.2. 
Then, the influence of deoxygenation on the  determina- 
tion of STR was studied and it was observed that the dis- 
solved oxygen did not interfere when a preconcentration of 
30 s (Eacc: −1.2 V versus AgCl/Ag) was applied, even when 
low scan rates and concentrations (10−7 mol L−1) were used 
(Fig. 2). The possibility of performing the measurements 
without the previous deoxygenation step allows a significant 
reduction of the analysis’ time and the possibility of includ- 
ing the HMDE in a flow injection system, without prior or 
on-line oxygen removal, which leads to an increase in sample 
rate. 
Based on the previous results, a flow injection system 
was developed, in which the adsorption step at the HMDE 
was performed, while the sample solution slug was flowing 
through the adapter head containing the mercury electrode. 
The square wave voltammetric scan was also performed un- 
der flow conditions and no perturbation of the voltammetric 
signal due to the flow of the electrolyte was observed. The 
length of the tube between the injection valve and the HMDE 
was kept as short as possible in order to minimise dispersion 
of the injected sample, and to keep the injected slug as intact 
as possible. In such conditions, it was possible to obtain    a 
  
 
 
 
Fig. 2. Influence of dissolved oxygen on the voltammetric determination of STR. STR concentration: (A) 0 mol L−1 and (B) 5 × 10−7 mol L−1. Deoxygenation 
time: (I) 0 s and (II) 600 s. Eacc: −1.2 V, tacc: 30 s, f: 50 Hz, Estep: 5 mV and Eampl: 25 mV. 
 
 
constant concentration sample zone passing at the electrode 
with a thickness depending on the injection volume (fixed at 
500 µL) and on the flow rate. At higher flow rates, the pe- 
riod of constant concentration throughput becomes smaller, 
reducing the time available for the adsorption and voltam- 
metric scan steps to be performed. 
Addition of methanol to the sample solution led to a sig- 
nificant increase in peak current intensity (ip) (Fig. 3) and 
precision. However, for methanol contents higher than 10% 
(v/v) no further increase in ip and poor peak definitions were 
obtained, reason why sample solutions were prepared in elec- 
trolyte solution containing 10% (v/v) methanol. 
Flow rates up to 1.1 mL min−1 were found not to have a 
great effect on the adsorption process. For higher flow rates, 
ip decreased significantly, probably due to the removal of ad- 
sorbed species at the electrode by the flow of electrolyte. The 
adopted flow rate was 1.1 mL min−1, a good compromise be- 
tween high sample rate and sensitivity. Using this flow rate, 
 
 
 
 
Fig. 3. Flow injection voltammograms of a 5 × 10−6 mol L−1 STR solution 
in pH 8.2 buffer, containing: (A) 0%, (B) 5% and (C) 10% (v/v) methanol. 
Eacc: −1.2 V,  tacc: 5 s, f: 10 Hz, Estep: 8 mV,  Eampl: 45 mV and flow   rate: 
1.1 mL min−1. 
 
an injection volume of 500 µL and a tube length of 50 cm 
between the injector and the detector, a constant concentra- 
tion profile between 15 and 40 s after injection was obtained. 
Both the adsorption step and the voltammetric scan must be 
performed within this time interval. 
The applied accumulation potential was the same  used 
in batch conditions (−1.2 V versus AgCl/Ag). The effect of 
the accumulation time is depicted in Fig. 4, with a marked 
increase in ip when the accumulation time is increased from 0 
to 6 s. For longer accumulation times (up to 10 s) ip levels off, 
possibly due to saturation of the drop coverage, to competitive 
adsorption or to removal of species by the flow. 
In order to obtain maximum sensitivity and reproducibil- 
ity/repeatability, several other SWAdSV parameters, the fre- 
quency, the pulse step and the pulse amplitude, were studied 
and optimised. These parameters are interrelated and  have 
a combined impact on the signal. In order to find the op- 
timum conditions, experiments were carried out using dif- 
ferent frequencies (10–100 Hz), pulse steps (1–10 mV) and 
pulse amplitudes (5–40 mV). From these studies, the opti- 
mum conditions for the determination of STR were estab- 
lished as f = 10 Hz, Estep =5 mV and Eampl = 25 mV. Using 
these optimised conditions, a good linear correlation between 
ip  and STR concentration was obtained for the    concentra- 
tion interval between 0.20 × 10−6 and 1.20 × 10−6 mol L−1 
 
 
 
Fig. 4. Variation of ip with accumulation time for a 2 × 10−6 mol L−1 STR 
solution. 
  
 
Fig. 5. Typical flow injection voltammograms obtained in the quantification 
of STR in a pharmaceutical preparation (Zoloft) using the standard addition 
method. Standard additions of STR (10−7 mol L−1): 0, 3.00, 4.00, 5.00 and 
6.00. Eacc: −1.2 V, tacc: 15 s, f: 10 Hz, Estep: 5 mV, Eampl: 25 mV and flow 
rate: 1.1 mL min−1. 
 
 
(ip = 0.939cSTR + 2.05 × 10−8; r = 0.995, n = 5). The limits 
of detection (LOD) and quantification (LOQ) were    calcu- 
lated using this calibration curve [22], and were found to 
be 1.5 × 10−7 and 5.0 × 10−7 mol L−1, respectively. Up to 
70 samples could be analysed per hour with good precision 
(R.S.D. = 2.5% (n = 10) at a 1.0 × 10−6 mol L−1 concentra- 
tion level). 
At the moment, the only commercially available phar- 
maceutical on the Portuguese market that contains STR is 
Zoloft (Pfizer Inc.). The labelled value of STR per tablet is 
50 mg. In order to evaluate the adequacy of the developed 
method, it was applied to the determination of STR in this 
pharmaceutical by the standard addition method. In Fig. 5, 
typical flow injection voltammograms corresponding to the 
quantification of STR in Zoloft are shown. A mean result of 
48.3 ± 2.4 mg/tablet (n = 3) was obtained, which conforms to 
the labelled value (50 mg/tablet). 
 
 
4. Conclusions 
 
In this work, a method for the determination of STR was 
developed, using adsorptive voltammetry and a HMDE flow 
cell. The method can be applied as a good alternative to chro- 
matographic methods for the determination of STR in phar- 
maceutical preparations. It has the advantages of significantly 
reducing the analysis’ time and costs and obtaining a high 
sample rate. 
 
Further investigation is undertaken in order to determine 
STR in biological samples using on-line sample extraction 
and the HMDE flow cell as a HPLC detector. 
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